Analystreport

Ligand Pharmaceuticals (NASDAQ:LGND) was upgraded by analysts at Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.

Ligand Pharmaceuticals Incorporated  (LGND) 
Last ligand pharmaceuticals incorporated earnings: 2/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.ligand.com